The PD-1/PD-Ls pathway and autoimmune diseases

Area of Science:

• Immunology
• Molecular Biology

Background:

• The programmed death (PD)-1/PD-1 ligands (PD-Ls) pathway is a key regulator of T-cell activation and immune tolerance.
• This pathway, part of the B7/CD28 family, includes the PD-1 receptor and its ligands PD-L1 and PD-L2.
• Soluble forms of PD-1, PD-L1, and PD-L2 have been identified, adding complexity to the pathway's function.

Purpose of the Study:

• To review the relevance of soluble PD-1/PD-Ls forms.
• To summarize recent research on the role of the PD-1/PD-Ls pathway in autoimmune diseases.

Main Methods:

• Literature review of existing studies on the PD-1/PD-Ls pathway.
• Analysis of research on soluble forms and their implications.
• Focus on the pathway's involvement in autoimmune conditions.

Main Results:

• The PD-1/PD-Ls pathway plays broad immunoregulatory roles beyond other B7/CD28 members.
• It is crucial for maintaining peripheral tolerance and protecting against autoimmune attacks.
• The pathway is implicated in various T-cell mediated diseases, including autoimmunity, cancer immunity, infections, and transplantation.

Conclusions:

• Soluble forms of PD-1/PD-Ls contribute to the pathway's functional diversity.
• The PD-1/PD-Ls pathway is a significant factor in the pathogenesis and regulation of autoimmune diseases.